Literature DB >> 20594037

Use of electron microscopy in core biopsy diagnosis of oncocytic renal tumors.

N B Johnson1, M M Johnson, M K Selig, G P Nielsen.   

Abstract

The distinction between oncocytoma and chromophobe renal cell carcinoma, important clinically, may be challenging, especially as the tissue sample size decreases. Ancillary studies can be helpful, although subject to interpretation and sample variability. The aim of this study was to examine the value of electron microscopy in differentiating between oncocytoma and chromophobe renal cell carcinoma on formalin fixed paraffin embedded needle core biopsies. Twenty renal needle core biopsies were evaluated. Despite formalin fixation and paraffin embedding, the classic ultrastructural features of these neoplasms were retained, revealing 80% sensitivity and 100% specificity by initial work-up.

Entities:  

Mesh:

Year:  2010        PMID: 20594037     DOI: 10.3109/01913121003725713

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  4 in total

Review 1.  99mTc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide.

Authors:  Scott P Campbell; Antonios Tzortzakakis; Mehrbod S Javadi; Mattias Karlsson; Lilja B Solnes; Rimma Axelsson; Mohamad E Allaf; Michael A Gorin; Steven P Rowe
Journal:  Br J Radiol       Date:  2018-02-27       Impact factor: 3.039

Review 2.  A review of 99mTc-sestamibi SPECT/CT for renal oncocytomas: A modified diagnostic algorithm.

Authors:  Mitchell P Wilson; Prayash Katlariwala; Jonathan Abele; Gavin Low
Journal:  Intractable Rare Dis Res       Date:  2022-05

Review 3.  The value of sestamibi single-photon emission computed tomography/computed tomography in differentiating and staging renal cell carcinomas: A systematic review.

Authors:  Abdalla Ali Deb; Ayman Agag; Naufal Naushad; Rajbabu Krishnamoorthy; Hosam Serag
Journal:  Curr Urol       Date:  2022-02-17

4.  Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma.

Authors:  Steven P Rowe; Michael A Gorin; Jennifer Gordetsky; Mark W Ball; Phillip M Pierorazio; Takahiro Higuchi; Jonathan I Epstein; Mohamad E Allaf; Mehrbod S Javadi
Journal:  Clin Nucl Med       Date:  2015-04       Impact factor: 7.794

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.